Hege Sagstuen Haugnes
Job description
Jeg jobber som professor i onkologi i 50% stilling ved UiT, kombinert med 50% stilling som seksjonsoverlege i uro-onkologi ved Universitetssykehuset Nord-Norge
Hege Sagstuen,
Håkon,
Eivind,
Ragnhild,
Line Veronika,
Magnus
:
Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
Acta Oncologica 2025 DOI
Selina R. van den,
Renée L.,
Kevin C.,
Jourik A.,
Roderick,
Louis S.
et al.:
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group
European Journal of Endocrinology (EJE) 2025 DOI
Sophie Dorothea,
Lars Johan,
Torgrim,
Marianne,
Alv A,
Ragnhild Veline
et al.:
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Anna,
Mette Pernille,
Anna Grenabo,
Per-Olof,
Viktor,
Bjarte
et al.:
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Martin,
Tore,
Einar,
Ingvild,
Tom,
Anne Elise
et al.:
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
Rune,
Hege Sagstuen,
Alexander,
Ola,
Ida,
Miguel
et al.:
Behandling av kastrasjonsresistent metastatisk prostatakreft med [177Lu]PSMA-radioligand
Axel,
Helene Francisca Stigter,
Bjarte,
Anna Grenabo,
Gabriella,
Ingrid
et al.:
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
Anna,
Helene Francisca Stigter,
Anna Grenabo,
Bjarte,
Signe Melsen,
Per-Olof
et al.:
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Sophie Dorothea,
Hege Sagstuen,
Alv A,
Cecilie E.,
Alexander,
Jakob Rasmussen
et al.:
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Annals of Oncology 21. September 2023 DOI
Axel,
Gustav,
Anna,
Anna Grenabo,
Bjarte,
Ulf
et al.:
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
Marie Grøn,
Line Veronika,
Erling Johan,
Tore,
Sigve,
Anne Gry
et al.:
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Ramesh,
Elia,
Hege Sagstuen,
Cecilie E.,
Ruby del Risco
:
Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway
Line Veronika,
Marie Grøn,
Erling Johan,
Tore,
Sigve,
Anne Gry
et al.:
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Lene,
Kerry S.,
Jostein,
Jon Michael,
Hege Sagstuen,
Helene Francisca Stigter
et al.:
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Einar,
Tom,
Hege Sagstuen,
Mona Irene,
Tore,
Martin
et al.:
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Jan,
D.M.,
C.,
Miguel Angel,
G.,
Jourik A.
et al.:
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology 2022 DOI
Sophie Dorothea,
Alv A,
Lene,
Ragnhild,
Cecilie E.,
Torgrim
et al.:
Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Mette Pernille,
Anna,
Nina Benedikte,
Peder,
Åsa,
Marianne
et al.:
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Axel,
Anna,
Anna Bergdahl,
Bjarte,
Ulf,
Magnus
et al.:
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
European Urology Oncology (EUO) 06. März 2021 DOI
Anders W.,
Sophie Dorothea,
Hege Sagstuen,
Ragnhild Veline,
Thomas Muri,
Kristina
et al.:
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: A 30-year follow-up
Ragnhild,
Tor Åge,
Roy M.,
Åsa,
Øivind,
Helene Francisca Stigter
et al.:
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Hege S.,
Helene Francisca Stigter,
Hilde,
Tom,
Torgrim,
Arne
:
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
Einar,
Henrik,
Tore,
Martin,
Tom,
Edward L.
et al.:
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
Ragnhild,
Tor Åge,
Sophie Dorothea,
Roy M.,
Åsa,
Øivind
et al.:
Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
Synne-Kristin Hoffart,
Hanne Cathrine,
Kristin Valborg,
Sophie Dorothea,
Hege Sagstuen,
Cecilie E.
et al.:
Lifestyle among long-term survivors of cancers in young adulthood
Hanne Skjerven,
Hege Sagstuen,
Alv A,
Unn-Merete,
Øystein,
Harald
et al.:
Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
Bone Marrow Transplantation 03. November 2020 DOI
Axel,
Ulf,
Magnus,
George,
Helene Francisca Stigter,
Ingrid
et al.:
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Lene,
Hege Sagstuen,
Sophie Dorothea,
Marianne,
Torgrim,
Torbjørn
et al.:
Thromboembolic events after high-intensity training duringcisplatin-based chemotherapy for testicular cancer: Casereports and review of the literature
Ruby Del Risco,
Hege Sagstuen,
Bjørgulf,
Magne,
Per,
James
et al.:
A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USA.
Sophie Dorothea,
Alv A,
Tor Åge,
Cecilie E.,
Ragnhild Veline,
Olbjørn
et al.:
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Cancer Epidemiology 09. Juli 2020 DOI
Ruby Del Risco,
LA,
Hege Sagstuen,
Ellen,
Magne,
Per
et al.:
Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.
Synne-Kristin Hoffart,
Lene,
Cecilie E.,
Sophie Dorothea,
Hanne Cathrine,
Jon Håvard
et al.:
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Hanne Skjerven,
Hege Sagstuen,
Unn-Merete,
Øystein,
Harald,
Knut Bjøro
et al.:
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
Hanne Skjerven,
Hege Sagstuen,
Alv A,
Unn-Merete,
Øystein,
Harald
et al.:
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
Einar,
Elin,
Tore,
Tom,
Edward L.,
Anne
et al.:
Inflammatory serum markers and risk and severity of prostate cancer: The PROCA‐life study
Cecilie,
Christian Magnus,
Trine B.,
Marcin,
Sophie Dorothea,
Tom
et al.:
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
Yahia,
Ingrid,
Carina Berglund,
Gabriella,
Olof,
Torgrim
et al.:
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
Ruby Del Risco,
Ellen,
Hege Sagstuen,
Lisa A.,
Magne,
Per
et al.:
Family history of cancer and risk of paediatric and young adult’s testicular cancer: A Norwegian cohort study
Ragnhild,
Øivind,
Tor Åge,
Roy M.,
Åsa,
Helene Francisca Stigter
et al.:
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
F,
J,
D,
J,
C,
R
et al.:
ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up
Annals of Oncology 2018 DOI
Line Veronika,
Per Ole Mobråten,
Ragnhild,
Mette,
Marianne,
Torgrim
et al.:
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Acta Oncologica 2018 DOI
Marie K,
Carina,
Gabriella,
Hege Sagstuen,
Torgrim,
Carl W.
:
Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA
Acta Oncologica 2018 DOI
Sven,
Helena Maria,
Christoph Rainer,
Kirsti,
Hege Sagstuen,
Bjørg Yksnøy
et al.:
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
Torgrim,
Ragnhild,
Åsa,
Øivind,
Carl W.,
Helene Francisca Stigter
et al.:
Late relapse in testicular cancer: A report from a national cohort. Oral presentation
2022
Ingerid Skjei,
Bendik Skarre,
Kirsten Margrete,
Mattijs,
Sverre,
Thomas
et al.:
PSMA-PET-avbildning før primærbehandling av pasienter med høyrisiko prostatakreft
2022
Torgrim,
Ragnhild,
Hege Sagstuen,
Åsa,
Carl W.,
Helene Francisca Stigter
et al.:
Late relapses in testicular cancer: Results from a national cohort
Hege Sagstuen
:
Presentasjon av kreft seneffekt poliklinikken ved UNN
2022
Hege Sagstuen
:
Presentasjon av seneffekt poliklinikken ved UNN
2022
B.,
A.,
F.,
G.,
Hege Sagstuen,
P.
et al.:
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
Annals of Oncology 2020 DOI
Einar,
Hege Sagstuen,
Inger,
Tom,
Anne Elise,
Tore
et al.:
Pre-diagnostic Inflammation Score and risk of Prostate Cancer. The PROCA-life study
2018
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Jeg er opptatt av forskning med fokus på 1) seneffekter etter kreftbehandling, 2) diagnostikk, behandling og oppfølging innen urologisk kreft (med fokus på testikkelkreft og prostatakreft) og 3) kliniske kreftforskningsprosjekter knyttet til Tromsøundersøkelsen (prostatakreft og brystkreft).
Teaching
Jeg har mange års erfaring med å undervise i onkologi ved medisinstudiet, og er hovedansvarlig for delemne 6.4F ved campus Hammerfest.